Massimo Serra got the Degree in Biological Sciences (score of 110 out of 110, with high honours). Since 1989, he is employed as Staff Researcher (Biologo Dirigente I Livello) at the Laboratory of Experimental Oncology of the Orthopaedic Rizzoli Institute, I.R.C.C.S.(Bologna, Italy). He also worked abroad as Research Fellow at the "Molecular Genetics Laboratory" (Salk Institute, San Diego, CA) in 1993 and as Research Fellow at the "Cytogenetics and Molecular Genetics Laboratory" of the University of Helsinki (Finland) in 1997. From 1999 to 2008, he has been the Chief of the "Drug Resistance" Research Unit (Modulo Organizzativo), which was upgraded to the "Pharmacogenomics and Pharmacogenetics" Research Unit (Struttura Semplice) on 2009, at the Laboratory of Experimental Oncology of the Orthopaedic Rizzoli Institute. From 1998 to 2008, he has been member of the Scientific Committee of the Orthopaedic Rizzoli Institute and of the Directive Committee of the Musculo-Skeletal Oncology, department of the Orthopaedic Rizzoli Institute. Since 2009, he is member of the Direction Committee of the Orthopaedic Rizzoli Institute. Massimo Serra got the Degree in Biological Sciences (score of 110 out of 110, with high honours). Since 1989, he is employed as Staff Researcher (Biologo Dirigente I Livello) at the Laboratory of Experimental Oncology of the Orthopaedic Rizzoli Institute, I.R.C.C.S.(Bologna, Italy). He also worked abroad as Research Fellow at the "Molecular Genetics Laboratory" (Salk Institute, San Diego, CA) in 1993 and as Research Fellow at the "Cytogenetics and Molecular Genetics Laboratory" of the University of Helsinki (Finland) in 1997. From 1999 to 2008, he has been the Chief of the "Drug Resistance" Research Unit (Modulo Organizzativo), which was upgraded to the "Pharmacogenomics and Pharmacogenetics" Research Unit (Struttura Semplice) on 2009, at the Laboratory of Experimental Oncology of the Orthopaedic Rizzoli Institute. From 1998 to 2008, he has been member of the Scientific Committee of the Orthopaedic Rizzoli Institute and of the Directive Committee of the Musculo-Skeletal Oncology, department of the Orthopaedic Rizzoli Institute. Since 2009, he is member of the Direction Committee of the Orthopaedic Rizzoli Institute.

Pharmacogenomics and Pharmacogenetics